Fertility ELISA
Enzyme Immunoassay for the Quantitative
Determination of Follicle-Stimulation Hormone (FSH)
Concentration in Human Serum
Enzyme Immunoassay for the Quantitative
Determination of Cardiac-Specific Troponin-I
in Human Serum
for in vitro diagnostic use
Product Description
Follicle-Stimulation Hormone (FSH) and Luteinizing Hormone
(LH) are intimately involved in the control of the growth
and reproductive activities of the gonadal tissues, which
synthesize and secrete male and female sex hormones. The levels
of circulating FSH and LH are controlled by these sex hormones
through a negative feedback relationship.
FSH is a glycoprotein secreted by the basophilic cells of
the anterior pituitary. Gonadotropin-release hormone (GnRH),
produced in the hypothalamus, controls the release of FSH
from the anterior pituitary. Like other glycoproteins, such
as LH, TSH, and hCG, FSH consists of subunits designated as
alpha and beta. Hormones of this type have alpha subunits
that are very similar structurally; therefore the biological
and imunological properties are dependent on the unique beta
subunits.
In the female, FSH stimulates the growth and maturation of
ovarian follicles by acting directly on the receptors located
on the grannulosa cells; follicular steroidogenesis is promoted
and LH production is stimulated. The LH produced then binds
to the theca cells and stimulates steroidogenesis. Increased
intraovarian estradiol production occurs as follicular maturation
advances, thereupon stimulating increased FSH receptor activity
and FSH follicular binding. FSH, LH, and estradiol are therefore
intimately related in supporting ovarian recruitment and maturation
in women.
FSH levels are elevated after menopause, castration, and
in premature ovarian failure. The levels of FSH may be normalized
through the administration of estrogen, which demonstrate
a negative feedback mechanism. Abnormal relationships between
FSH and LH and between FSH and estrogen have been linked to
anorexia nerbosa and polycystic ovarian disease. Although
there are significant exceptions, ovarian there are significant
exceptions, ovarian failure is indicated when random FSH concentrations
exceed 40mIU/ml.
The growth of the seminiferous tubules and maintenance of
spermatogenesis in men are regulated by FSH. However, androgens,
unlike estrogen, do not lower FSH levels, therefore demonstrating
a feedback relationship only with serum LH.
For reasons not fully understood, azospermic and oligospermic
males usually have elevated FSH levels. Tumors of the testes
generally depress serum FSH concentrations. High levels of
FSH in men may be found in primary testicular failure and
Klinefelter syndrome. Elevated concentrations are also present
in cases of starvation, renal failure, hyperthyroidism, and
cirrhosis.
Principle
The FSH Quantitative Test is based on a solid phase enzyme-linked
immunosorbent assay (ELISA). The assay system utilizes a mouse
monoclonal anti-α-FSH antibody for solid phase (microtiter
wells) immobilization and another mouse monoclonal anti-β-FSH
antibody in the antibody-enzyme (horseradish peroxidase) conjugate
solution.
The test sample is allowed to react simultaneously with the
antibodies, resulting in FSH molecules being sandwiched between
the solid phase and enzyme-linked antibodies.
After a 45-minute incubation at room temperature, the wells
are washed with water to remove unbound-labeled antibodies.
A solution of TMB Reagent is added and incubated at room temperature
for 20 minutes, resulting in the development of a blue color.
The color development is stopped with the addition of Stop
Solution and the color is changed to yellow and measured spectrophotometrically
at 450nm.
The concentration of FSH is directly proportional to the color
intensity of the test sample.
Downloads: (Must be logged in)
Instruction PDF
|
 |
 |
|